About Europe CBD Expo
Located at the home of world leading events ExCeL London, UK, this 2-day hybrid business and consumer trade show and conference dedicated entirely to CBD (Cannabidiol) will feature more than 80 exhibitors, a CBD Link Educational and Networking Area. Attendees will have the opportunity to participate in panel discussions from experts in the research, development, and distribution of CBD products, network, help remove stigma surrounding the industry and grow businesses.
Features
4
WORKSHOPS
30
SPEAKERS +
81
EXHIBITORS
100
PRESS & INFLUENCERS
Speakers
Sponsors
Partners
Agenda
July 12
09:30 – 10:00
Awaiting Confirmation
10:00 – 10:30
SESSION 1 – Cannabis Regulatory Intelligence
Medical Cannabis and CBD Products in the UK – Quality, Responsibility, Transparency.
MAIN STAGE
Blair Gibbs
Policy Lead, Centre for Medicinal Cannabis (CMC)
10:30 – 11:00
SESSION 1 – Cannabis Regulatory Intelligence
The European regulatory framework for CBD and appetite amongst European regulators and the banking sector to provide support to the industry
MAIN STAGE
Mark Taylor
Compliance and Regulatory Journalist
11:00 – 11:30
SESSION 1 – Cannabis Regulatory Intelligence
Israel Regulatory Standards Vs European Standards
MAIN STAGE
Golan Bitton
CEO, Univo Pharmaceuticals
11:30 – 12:00
COFFEE BREAK
12:00 – 12:30
SESSION 1 – Cannabis Regulatory Intelligence
Regulatory and Market Intelligence for the CBD Sector
MAIN STAGE
Tim Phillips
Managing Director, CBD Intel
12:30 – 13:15
Panel Discussion
European Regulations, Insights & Opportunities – Where are we now? The Future of Cannabis and CBD
Chaired by Karina Lahnakoski
VP of Quality & Regulatory, Cannabis Compliance Inc.
George McBrid
CEО, Hanway Associates
Housam Nasr
COO, London Canna Group
Eveline Van Keymeule
Counsel, Allen & Overy
Blair Gibbs
Policy Lead, Centre for Medicinal Cannabis (CMC)
Hassan Akhtar
Managing Director, CBD Capital
13:15 – 13:45
KEYNOTE SPEAKER
Awaiting Confirmation
13:45 – 14:15
SESSION 2 – Cannabinoid Development Strategies
Investing in Cannabinoids, cultivation, product development, branding and distribution
MAIN STAGE
Patrick Morton
Co-Founder, Cannabis Invest UK
14:15 – 14:45
SESSION 2 – Cannabinoid Development Strategies
Making CBD, Cannabinoids and Medicinal Cannabis affordable: How Emerging Markets will disrupt the global supply chain
MAIN STAGE
Oliver Zugel
Founder and CEO, Foliumed
14:45 – 15:15
SESSION 2 – Cannabinoid Development Strategies
CBD, Cannabinoids and Medicinal Cannabis Formulation & Product Development Strategies
MAIN STAGE
Dr Monica Vialpando
Founder, Vialpando LLC
15:15 – 15:45
SESSION 2 – Cannabinoid Development Strategies
Awaiting Talk Title
MAIN STAGE
Josh Crossney
CEO, Cannabis Science Conference
15:45 – 16:15
SESSION 3 – The Necessity of Cannabis Testing
Awaiting Talk Title
MAIN STAGE
Tracy Szerszon
President, Perry Johnson Lab Accreditation Inc
16:15 – 16:45
SESSION 3 – The Necessity of Cannabis Testing
Determination of CBD and General Cannabinoid Content in Hemp Oils
MAIN STAGE
Dr Richard Hodgson
LC Technical Specialist, Shimadzu
16:45 – 17:15
SESSION 3 – The Necessity of Cannabis Testing
Optimizing Cannabis Testing with Mass Spectrometry
MAIN STAGE
Daniel McMillan
Sr. Manager, SCIEX
17:15 – 17:55
Panel Discussion
Emerging Markets and International Trends – International Insights, Opportunities and Investment
MAIN STAGE
Chaired by Stephen Murphy
CEO, Prohibition Partners
Michael Patterson
CEO, US Cannabis Pharmaceutical Research and Development LLC (USA)
Golan Bitton
CEO, Univo Pharmaceuticals (Israel)
Oliver Zugel
Founder and CEO, Foliumed (Columbia)
Costas Vamvakas
Managing Director, VK PREMIUM Business Consultants Ltd. (Greece)
Mait Soosalu
Advance Biotech Laboratories (Sweden AB)
18:00 – 19:30
Drinks Reception
Evening Entertainment
MAIN HALL & NETWORK AREAS
Band
The What if Generation
July 13
10:00 – 10:30
KEYNOTE
Dr. Zeid Mohamedali
Chief Medical Officer, Zenabis
10:30 – 11:00
SESSION 1 – A Guide to CBD, Cannabinoids and Medical Cannabis
CBD & Cannabinoids for Everyone
MAIN STAGE
Dr Dani Gordon
Doctor, Author, ABIHM, ABIOM
11:00 – 11:30
SESSION 1 – A Guide to CBD, Cannabinoids and Medical Cannabis
Awaiting Talk Title
MAIN STAGE
Prof. Ram Reifen
Director, the Research Centre for Nutrigenomics and Functional Foods, Hebrew University of Jerusalem
11:30 – 12:00
SESSION 1 – A Guide to CBD, Cannabinoids and Medical Cannabis
Pure CBD Vs Whole Plant Preparations
MAIN STAGE
Gregor Zorn
Director and Co-Founder, ECTA, European Cannabinoid Therapy Association
12:00 – 12:30
SESSION 2 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence
Medical Cannabis – From bench to bedside
MAIN STAGE
Mikael Sodergren
Clinical Lecturer in Surgery, Imperial College London
12:30 – 13:00
SESSION 2 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence
Haemodynamic effects of Cannabidiol in humans
MAIN STAGE
Dr Saoirse O’sullivan
Professor, University of Nottingham
13:00 – 13:30
SESSION 2 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence
Research on Cannabis in Cancer
MAIN STAGE
Prof Dr Tamara Lah
Counselor to the Director National Institute of Biology, Slovenia
13:30 – 14:00
KEYNOTE
Prof. Mike Barnes
Chief Medical Officer, European Cannabis Holdings (ECH)
14:00 – 14:45
Panel Discussion
Medical Cannabis Access and Patient Care
Chaired by Prof. Mike Barnes
Chief Medical Officer, ECH, European Cannabis Holdings
Basia Zieniewicz
Co-Founder, Families 4 Access
Hannah Deacon
Patient Advocate, End Our Pain
Irit Avisar
Chairperson, Israeli Medical Cannabis Nurses Association
Carly Barton
Patient Advocate, United Patients Alliance
14:45 – 15:15
SESSION 3 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
Awaiting Talk Title
MAIN STAGE
Irit Avisar
Chairperson, Israeli Medical Cannabis Nurses Association
15:15 – 15:45
SESSION 3 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
Novel synergistic cannabinoid combinations for the treatment of IBS and IBD patients
MAIN STAGE
Zohar Koren Phd
CEO, SciCann Therapeutics Inc.
15:45 – 16:15
SESSION 3 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
MAIN STAGE
Alex Fraser
Patient Access Specialist, Grow Biotech
16:15 – 17:00
Panel Discussion
Women – The Future of Cannabis
MAIN STAGE
Chaired by Kristina Spionjak
Marketing Director, London Canna Group
Dr Dani Gordon
Doctor, Author, ABIHM, ABIOM
Dr Saoirse O’sullivan
Professor, University of Nottingham
Jasmin Thomas
Founder, Ohana CBD
Joanna Weaver-Pélissier
CEO, BeCann
Róisín Delaney
Editor, Vapouround CBD
Dr Monica Vialpando
Founder, Vialpando LLC
17:00 – 17:30
Celebrity Event Closing Giveaway
Ignite CBD Prize Giveaways
Dan Bilzerian
